Immunological Abnormalities In PCOS
DOI:
https://doi.org/10.12775/QS.2024.36.56517Keywords
immunology, polycystic ovary syndrome, infertility, cytokinesAbstract
PCOS (Polycystic Ovary Syndrome) is a condition associated with irregular ovulation, hyperandrogenism and metabolic disturbances. It affects 10-15% of reproductive ages and it is a common reason for infertility. The basis of PCOS is chronic low-grade inflammation, which is expressed by an increase in inflammatory biomarkers such as CRP, IL6, IFN gamma, TNF alpha, IL10, 17,18 MCP-1 and an increase in the percentage of lymphocytes especially Th1 and macrophages, eosinophils compared to the healthy population. The hormonal imbalances in PCOS may contribute to dysregulation of the immune system, leading to the production of a diverse range of autoantibodies for a spectrum of systemic connective tissue diseases, lupus erythematosus, scleroderma, dermatomyositis, polymyositis, and Sjögren's syndrome. This article reviews the results of previous research on this topic. It was prepared to summarize the latest knowledge about immunological abnormalities in PCOS and to define new therapeutic drug action points.
References
Wang J, Yin T, Liu S. Dysregulation of immune response in PCOS organ system. Front Immunol. 2023;14:1169232.
Christ JP, Cedars MI. Current Guidelines for Diagnosing PCOS. Diagnostics (Basel). 2023;13(6).
Smet ME, McLennan A. Rotterdam criteria, the end. Australas J Ultrasound Med. 2018;21(2):59-60.
Kostroun KE, Goldrick K, Mondshine JN, Robinson RD, Mankus E, Reddy S, et al. Impact of updated international diagnostic criteria for the diagnosis of polycystic ovary syndrome. F S Rep. 2023;4(2):173-8.
Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-69.
Sarray S, Almawi WY. Levels of CD40L and other inflammatory biomarkers in obese and non-obese women with polycystic ovary syndrome. Am J Reprod Immunol. 2016;76(4):285-91.
Niccoli G, Apa R, Lanzone A, Liuzzo G, Spaziani C, Sagnella F, et al. CD4+CD28 null T lymphocytes are expanded in young women with polycystic ovary syndrome. Fertil Steril. 2011;95(8):2651-4.
Zhao J, Dong L, Lin Z, Sui X, Wang Y, Li L, et al. Effects of selenium supplementation on Polycystic Ovarian Syndrome: a systematic review and meta-analysis on randomized clinical trials. BMC Endocr Disord. 2023;23(1):33.
Panidis D, Tziomalos K, Papadakis E, Vosnakis C, Chatzis P, Katsikis I. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Endocrine. 2013;44(3):583-90.
Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab. 2021;106(3):e1071-e83.
Pkhaladze L, Russo M, Unfer V, Nordio M, Basciani S, Khomasuridze A. Treatment of lean PCOS teenagers: a follow-up comparison between Myo-Inositol and oral contraceptives. Eur Rev Med Pharmacol Sci. 2021;25(23):7476-85.
Banerjee S, Cooney LG, Stanic AK. Immune Dysfunction in Polycystic Ovary Syndrome. Immunohorizons. 2023;7(5):323-32.
Zhang S, Gang X, Yang S, Cui M, Sun L, Li Z, et al. The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases. Front Immunol. 2021;12:678355.
Hu C, Pang B, Ma Z, Yi H. Immunophenotypic Profiles in Polycystic Ovary Syndrome. Mediators Inflamm. 2020;2020:5894768.
Gagliani N, Amezcua Vesely MC, Iseppon A, Brockmann L, Xu H, Palm NW, et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature. 2015;523(7559):221-5.
Zhang T, Tian F, Huo R, Tang A, Zeng Y, Duan YG. Detection of dendritic cells and related cytokines in follicular fluid of patients with polycystic ovary syndrome. Am J Reprod Immunol. 2017;78(3).
Nasri F, Doroudchi M, Namavar Jahromi B, Gharesi-Fard B. T Helper Cells Profile and CD4+CD25+Foxp3+Regulatory T Cells in Polycystic Ovary Syndrome. Iran J Immunol. 2018;15(3):175-85.
Stokkeland LMT, Giskeødegård GF, Ryssdal M, Jarmund AH, Steinkjer B, Madssen TS, et al. Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2022;107(1):39-52.
Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012;181(1):8-18.
Qin L, Xu W, Li X, Meng W, Hu L, Luo Z, et al. Differential Expression Profile of Immunological Cytokines in Local Ovary in Patients with Polycystic Ovarian Syndrome: analysis by Flow Cytometry. Eur J Obstet Gynecol Reprod Biol. 2016;197:136-41.
Barber TM, Hanson P, Weickert MO, Franks S. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042.
Gong P, Shi B, Wang J, Cao P, Diao Z, Wang Y, et al. Association between Th1/Th2 immune imbalance and obesity in women with or without polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(8):709-14.
Sala Elpidio LN, de Alencar JB, Tsuneto PY, Alves HV, Trento Toretta M, It Taura SK, et al. Killer-cell immunoglobulin-like receptors associated with polycystic ovary syndrome. J Reprod Immunol. 2018;130:1-6.
Whiteside TL. The natural killer (NK) cell and synergistic antitumor effects of interferon-gamma and interleukin-2. Cancer Invest. 1990;8(5):565-6.
Su J, Li Y, Su G, Wang J, Qiu T, Ma R, et al. Genetic association of CTLA4 gene with polycystic ovary syndrome in the Chinese Han population. Medicine (Baltimore). 2018;97(29):e11422.
Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958-69.
Yang Y, Xia J, Yang Z, Wu G, Yang J. The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients. J Ovarian Res. 2021;14(1):155.
Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326-36.
Akcalı A, Bostanci N, Özçaka Ö, Öztürk-Ceyhan B, Gümüş P, Buduneli N, et al. Association between polycystic ovary syndrome, oral microbiota and systemic antibody responses. PLoS One. 2014;9(9):e108074.
González F, Kirwan JP, Rote NS, Minium J. Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome. Am J Obstet Gynecol. 2014;211(6):635.e1-7.
Fulghesu AM, Sanna F, Uda S, Magnini R, Portoghese E, Batetta B. IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance. Mediators Inflamm. 2011;2011:389317.
Mobeen H, Afzal N, Kashif M. Polycystic Ovary Syndrome May Be an Autoimmune Disorder. Scientifica (Cairo). 2016;2016:4071735.
Deligeoroglou E, Vrachnis N, Athanasopoulos N, Iliodromiti Z, Sifakis S, Iliodromiti S, et al. Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol. 2012;28(12):974-8.
Sathyapalan T, Atkin SL. Mediators of inflammation in polycystic ovary syndrome in relation to adiposity. Mediators Inflamm. 2010;2010:758656.
Glintborg D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol. 2010;26(4):281-96.
Serin AN, Birge Ö, Uysal A, Görar S, Tekeli F. Hashimoto's thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels. BMC Endocr Disord. 2021;21(1):44.
Lederman S, Yellin MJ, Cleary AM, Pernis A, Inghirami G, Cohn LE, et al. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J Immunol. 1994;152(5):2163-71.
Dahan MH, Reaven G. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome. Endocrine. 2019;64(3):685-9.
Boraschi D, Dinarello CA. IL-18 in autoimmunity: review. Eur Cytokine Netw. 2006;17(4):224-52.
Kabakchieva P, Gateva A, Velikova T, Georgiev T, Yamanishi K, Okamura H, et al. Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome. Arch Endocrinol Metab. 2022;66(1):3-11.
Hu W, Qiao J, Yang Y, Wang L, Li R. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):53-6.
Lin YS, Tsai SJ, Lin MW, Yang CT, Huang MF, Wu MH. Interleukin-6 as an early chronic inflammatory marker in polycystic ovary syndrome with insulin receptor substrate-2 polymorphism. Am J Reprod Immunol. 2011;66(6):527-33.
Hefler-Frischmuth K, Walch K, Huebl W, Baumuehlner K, Tempfer C, Hefler L. Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril. 2010;93(7):2291-4.
Benson S, Janssen OE, Hahn S, Tan S, Dietz T, Mann K, et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun. 2008;22(2):177-84.
Zhao H, Zhang Y, Ye J, Wei H, Huang Z, Ning X, et al. A Comparative Study on Insulin Secretion, Insulin Resistance and Thyroid Function in Patients with Polycystic Ovary Syndrome with and without Hashimoto's Thyroiditis. Diabetes Metab Syndr Obes. 2021;14:1817-21.
Szczuko M, Zapałowska-Chwyć M, Maciejewska D, Drozd A, Starczewski A, Stachowska E. Significant Improvement Selected Mediators of Inflammation in Phenotypes of Women with PCOS after Reduction and Low GI Diet. Mediators Inflamm. 2017;2017:5489523.
Jorgovanovic D, Song M, Wang L, Zhang Y. Roles of IFN-γ in tumor progression and regression: a review. Biomark Res. 2020;8:49.
Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32(1):23-63.
Purkerson JM, Newberg M, Wise G, Lynch KR, Isakson PC. Interleukin 5 and interleukin 2 cooperate with interleukin 4 to induce IgG1 secretion from anti-Ig-treated B cells. J Exp Med. 1988;168(3):1175-80.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Joanna Maria Barcińska, Aleksandra Ostrowska-Czyżewska, Dominika Szwed
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 64
Number of citations: 0
